Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Imprimatur Capital Ltd

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 6
Rounds per year 0.39
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.14
Exits 1
Key employees 2
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Health Diagnostics
  • Clinical Trials
  • Medical Device
  • Biotechnology
  • Pharmaceutical
Summary

Imprimatur Capital Ltd appeared to be the VC, which was created in 2002. The venture was found in Europe in United Kingdom. The leading representative office of defined VC is situated in the London.

The overall number of key employees were 2.

The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Imprimatur Capital Ltd, startups are often financed by Scottish Investment Bank. The meaningful sponsors for the fund in investment in the same round are Xeraya Capital. In the next rounds fund is usually obtained by The North West Fund, Imprimatur Capital Fund Management, BaltCap.

The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars. Comparing to the other companies, this Imprimatur Capital Ltd performs on 15 percentage points less the average number of lead investments. The top activity for fund was in 2006. The real fund results show that this VC is 6 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2015.

We can highlight the next thriving fund investment areas, such as Biotechnology, Machine Learning. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Evgen Pharma, BigDNA, Boston Neurosciences Inc. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Imprimatur Capital Ltd:
Typical Co-investors
Imprimatur Capital Ltd is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Imprimatur Capital Ltd:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
CAC Holdings Japan, Tokyo
Chatur Ideas India, Maharashtra, Mumbai
Grand Prix Capital Australia, Bondi, New South Wales
Innovation Guelph Canada, Guelph, Ontario
InvestAmerican Investment Advisors Minneapolis, Minnesota, United States
JX Nippon Mining and Metals Corporation Japan, Tokyo
Kapital Partners California, Los Gatos, United States
KDI Precision Products Cincinnati, Ohio, United States
Loomis AB Stockholm, Stockholm County, Sweden
Mango Cultural and Creative Industry Private Equity Fund China, Shanghai
Meru Capital India, Maharashtra, Mumbai
Metric England, London, United Kingdom
NFT Investment -
RIDE ON EXPRESS HOLDINGS Japan Chiyoda, Japan
Sigma Designs California, Milpitas, United States
Testrite Group Taipei, Taiwan
Tianming Shuangchuang Technology China, Henan, Zhengzhou
Topband China, Guangdong, Shenzhen
Wavecrest Growth Partners Boston, Massachusetts, United States
Xietong Touzi China, Huangpu, Shanghai

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

afriQloud

Information Technology
01 Jun 2018 Kampala, Central Region, Uganda

Hertzian

Analytics
Artificial Intelligence
Big Data
Machine Learning
Natural Language Processing
Software
01 Jun 2016 Truro, Cornwall, United Kingdom

Clinical Trials
Health Diagnostics
Medical Device
$10M16 Oct 2015 Massachusetts, United States

Evgen Pharma

Biotechnology
Medical
Pharmaceutical
01 Sep 2009 England

BigDNA

Biotechnology
Pharmaceutical
Therapeutics
01 Jun 2008 Scotland

Clusterpoint

Database
Database Software
Information Technology
Network Management Software
Software
Software Development Applications
01 Jun 2006 London, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Imprimatur Capital Ltd?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 1M
Rounds per year 0.39
Peak activity year 2006
Lead investments 1
Follow on index 0.14
Exits 1
Group Appearance index 0.14

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

afriQloud

Information Technology
01 Jun 2018 Kampala, Central Region, Uganda

Hertzian

Analytics
Artificial Intelligence
Big Data
Machine Learning
Natural Language Processing
Software
01 Jun 2016 Truro, Cornwall, United Kingdom

Clinical Trials
Health Diagnostics
Medical Device
$10M16 Oct 2015 Massachusetts, United States

Evgen Pharma

Biotechnology
Medical
Pharmaceutical
01 Sep 2009 England

BigDNA

Biotechnology
Pharmaceutical
Therapeutics
01 Jun 2008 Scotland

Clusterpoint

Database
Database Software
Information Technology
Network Management Software
Software
Software Development Applications
01 Jun 2006 London, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: